Samuel Spector

1.7k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Samuel Spector is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Samuel Spector has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Genetics and 5 papers in Nutrition and Dietetics. Recurrent topics in Samuel Spector's work include Cystic Fibrosis Research Advances (8 papers), Neonatal Respiratory Health Research (4 papers) and Clinical Nutrition and Gastroenterology (2 papers). Samuel Spector is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Neonatal Respiratory Health Research (4 papers) and Clinical Nutrition and Gastroenterology (2 papers). Samuel Spector collaborates with scholars based in United States. Samuel Spector's co-authors include LeRoy W. Matthews, Joseph L. Potter, Joy Lemm, Carl F. Doershuk, Arthur S. Tucker, William A. Silverman, Alexander J. Schaffer, Alice G. Beard, Moses Grossman and Audrey K. Brown and has published in prestigious journals such as PEDIATRICS, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

In The Last Decade

Samuel Spector

28 papers receiving 1.1k citations

Hit Papers

COMMITTEE ON FETUS AND NEWBORN 1967 2026 1986 2006 1967 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Spector United States 16 724 259 160 139 113 28 1.2k
Milton E. Rubini United States 24 406 0.6× 140 0.5× 194 1.2× 280 2.0× 204 1.8× 65 1.6k
Michael E. Speer United States 22 337 0.5× 396 1.5× 122 0.8× 154 1.1× 354 3.1× 54 1.3k
George P. Giacoia United States 21 411 0.6× 654 2.5× 92 0.6× 245 1.8× 140 1.2× 78 1.4k
I. C. Radde Canada 22 453 0.6× 391 1.5× 266 1.7× 173 1.2× 230 2.0× 60 1.6k
Robert C. Borer United States 11 841 1.2× 294 1.1× 133 0.8× 496 3.6× 97 0.9× 27 1.3k
James M. Adams United States 17 510 0.7× 268 1.0× 106 0.7× 333 2.4× 198 1.8× 34 1.6k
W.K. Stewart United Kingdom 21 205 0.3× 111 0.4× 160 1.0× 207 1.5× 100 0.9× 89 1.3k
M. Obladen Germany 24 677 0.9× 517 2.0× 97 0.6× 186 1.3× 264 2.3× 77 1.6k
Yves W. Brans United States 22 478 0.7× 443 1.7× 45 0.3× 286 2.1× 103 0.9× 79 1.3k
C. Michael Bowman United States 19 1.5k 2.0× 85 0.3× 232 1.4× 201 1.4× 344 3.0× 39 1.9k

Countries citing papers authored by Samuel Spector

Since Specialization
Citations

This map shows the geographic impact of Samuel Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Spector more than expected).

Fields of papers citing papers by Samuel Spector

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Spector. The network helps show where Samuel Spector may publish in the future.

Co-authorship network of co-authors of Samuel Spector

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Spector. A scholar is included among the top collaborators of Samuel Spector based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Spector. Samuel Spector is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Potter, Joseph L., Samuel Spector, LeRoy W. Matthews, & Joy Lemm. (2015). Studies on Pulmonary Secretions. American Review of Respiratory Disease. 4 indexed citations
2.
Marsden, Deborah, Bruce A. Barshop, Christina Prodanos, et al.. (1994). Anabolic Effect of Human Growth Hormone: Management of Inherited Disorders of Catabolic Pathways. Biochemical Medicine and Metabolic Biology. 52(2). 145–154. 21 indexed citations
3.
Nyhan, William L., Michael Sawyer, Thomas E. Kearney, Samuel Spector, & Sarah A. Hilton. (1985). Lead intoxication in children.. PubMed Central. 143(3). 357–64. 6 indexed citations
4.
Kirschner, Barbara S., Irwin H. Rosenberg, & Samuel Spector. (1978). 446 USE OF ORAL NUTRITIONAL SUPPLEMENTS TO REVERSE GROWTH RETARDATION IN CHILDREN WITH CROHN'S DISEASE. Pediatric Research. 12. 438–438. 2 indexed citations
5.
Potter, Joseph L., Samuel Spector, LeRoy W. Matthews, & Joy Lemm. (1969). Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.. PubMed. 99(6). 909–16. 44 indexed citations
6.
Doershuk, Carl F., et al.. (1968). EVALUATION OF JET-TYPE AND ULTRASONIC NEBULIZERS IN MIST TENT THERAPY FOR CYSTIC FIBROSIS. PEDIATRICS. 41(4). 723–732. 12 indexed citations
7.
Gold, Hugo, Samuel Spector, Naguib A. Samaan, & Olof H. Pearson. (1968). Effect of growth hormone on carbohydrate metabolism in hypopituitary dwarfs. Metabolism. 17(1). 74–83. 29 indexed citations
8.
Matthews, LeRoy W., Carl F. Doershuk, & Samuel Spector. (1967). MIST TENT THERAPY OF THE OBSTRUCTIVE PULMONARY LESION OF CYSTIC FIBROSIS. PEDIATRICS. 39(2). 176–185. 30 indexed citations
9.
Phillips, Jerri Linn, et al.. (1966). Treatment of lead encephalopathy in children. The Journal of Pediatrics. 69(2). 198–206. 37 indexed citations
10.
Potter, Joseph L., LeRoy W. Matthews, Samuel Spector, & Joy Lemm. (1965). COMPLEX FORMATION BETWEEN BASIC ANTIBIOTICS AND DEOXYRIBONUCLEIC ACID IN HUMAN PULMONARY SECRETIONS. PEDIATRICS. 36(5). 714–720. 34 indexed citations
11.
Doershuk, Carl F., et al.. (1964). A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosis. The Journal of Pediatrics. 65(5). 677–693. 129 indexed citations
12.
Matthews, LeRoy W., et al.. (1964). A therapeutic regimen for patients with cystic fibrosis. The Journal of Pediatrics. 65(4). 558–575. 80 indexed citations
13.
Shojania, A. Majid, Samuel Gross, & Samuel Spector. (1964). Hemolytic anemia and folic acid deficiency in children. The Journal of Pediatrics. 65(1). 114–115. 1 indexed citations
14.
Matthews, LeRoy W., Samuel Spector, Joy Lemm, & Joseph L. Potter. (1963). STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY.. PubMed. 88. 199–204. 131 indexed citations
15.
Matthews, LeRoy W., et al.. (1962). The carbohydrate composition of pulmonary secretions. The Journal of Pediatrics. 61(2). 297–298. 1 indexed citations
16.
Matthews, LeRoy W. & Samuel Spector. (1961). "BREAK-THROUGH IN CYSTIC FIBROSIS". PEDIATRICS. 27(3). 351–353. 15 indexed citations
17.
Spector, Samuel, et al.. (1958). STUDY OF FAT ABSORPTION UTILIZING I131-LABELED CORN OIL IN INFANTS AND CHILDREN WITH AND WITHOUT STEATORRHEA. PEDIATRICS. 22(3). 515–524. 10 indexed citations
19.
Lavik, Paul S., et al.. (1952). USE OF I$sup 131$-LABELED PROTEIN IN THE STUDY OF PROTEIN DIGESTION AND ABSORPTION IN CHILDREN WITH AND WITHOUT CYSTIC FIBROSIS. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 4 indexed citations
20.
Spector, Samuel, et al.. (1951). The Effect of Pituitary Adrenocorticotrophic Hormone on Experimental Tetanus in Mice. The Journal of Infectious Diseases. 89(3). 224–225. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026